Francisco Ujueta/LinkedIn;
Eric A Secemsky/LinkedIn
Apr 12, 2026, 13:44
Francisco Ujueta: PAD VS CAD – Why Individualized Antithrombotic Strategies Matter
Francisco Ujueta, Vascular Cardiologist at Vanderbilt University Medical Center, shared a post on LinkedIn about a recent article he and his colleague co-authored, adding:
“View our commentary on differences in PAD and CAD – emphasizing higher ischemic and bleeding risks, greater heterogeneity, and the need for individualized antithrombotic strategies.”
Title: Too much, too little, or just right: Tailoring postrevascularization antithrombotic therapy in PAD versus CAD when one size does not fit all
Authors: Francisco Ujueta, Eric A Secemsky
Read the Full Article on Vascular Medicine
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026